Genmab A/S (GMAB)
35.32
+0.49
(+1.41%)
USD |
NASDAQ |
Sep 25, 16:00
35.30
-0.02
(-0.06%)
After-Hours: 19:59
Genmab Net Income (TTM) : 785.93M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 785.93M |
| March 31, 2026 | 823.88M |
| December 31, 2025 | 965.82M |
| September 30, 2025 | 1.485B |
| June 30, 2025 | 1.272B |
| March 31, 2025 | 1.135B |
| December 31, 2024 | 1.132B |
| September 30, 2024 | 674.78M |
| June 30, 2024 | 795.48M |
| March 31, 2024 | 787.32M |
| December 31, 2023 | 624.71M |
| September 30, 2023 | 612.46M |
| June 30, 2023 | 654.75M |
| March 31, 2023 | 730.23M |
| December 31, 2022 | 770.07M |
| September 30, 2022 | 800.07M |
| June 30, 2022 | 591.73M |
| March 31, 2022 | 370.82M |
| December 31, 2021 | 478.21M |
| September 30, 2021 | 461.24M |
| June 30, 2021 | 403.38M |
| March 31, 2021 | 852.58M |
| December 31, 2020 | 714.74M |
| September 30, 2020 | 839.79M |
| June 30, 2020 | 836.59M |
| Date | Value |
|---|---|
| March 31, 2020 | 350.56M |
| December 31, 2019 | 321.88M |
| September 30, 2019 | 231.28M |
| June 30, 2019 | 179.23M |
| March 31, 2019 | 208.10M |
| December 31, 2018 | 229.89M |
| September 30, 2018 | 226.69M |
| June 30, 2018 | 197.84M |
| March 31, 2018 | 201.68M |
| December 31, 2017 | 171.22M |
| September 30, 2017 | 168.80M |
| June 30, 2017 | 198.03M |
| March 31, 2017 | 178.07M |
| December 31, 2016 | 174.06M |
| September 30, 2016 | 109.30M |
| June 30, 2016 | 101.86M |
| March 31, 2016 | 78.77M |
| December 31, 2015 | 113.26M |
| September 30, 2015 | 67.71M |
| June 30, 2015 | 75.25M |
| March 31, 2015 | 68.00M |
| December 31, 2014 | 53.30M |
| September 30, 2014 | 52.64M |
| June 30, 2014 | 25.16M |
| March 31, 2014 | 25.53M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| AbbVie, Inc. | 6.274B |
| Ascendis Pharma A/S | 866.59M |
| Zealand Pharma A/S | 425.33M |
| Bavarian Nordic A/S | 241.04M |
| Evaxion AS | -8.683M |